Jane Street
LABD icon

Jane Street’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Jane Street’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Buy
203,500
+66,800
+49% +$1.26M ﹤0.01% 4155
2025
Q4 		$2.88M Buy
+136,700
New +$3.71M ﹤0.01% 4114
2022
Q2 		– Sell
-5,390
Closed -$1.89M – 10344
2022
Q1 		$1.89M Sell
5,390
-60
-1% -$23.5K ﹤0.01% 4866
2021
Q4 		$1.4M Sell
5,450
-500
-8% -$115K ﹤0.01% 5230
2021
Q3 		$1.27M Buy
5,950
+2,690
+83% +$572K ﹤0.01% 5433
2021
Q2 		$629K Sell
3,260
-3,740
-53% -$839K ﹤0.01% 6810
2021
Q1 		$1.52M Sell
7,000
-366
-5% -$71K ﹤0.01% 4555
2020
Q4 		$1.86M Buy
7,366
+6,694
+996% +$2.55M ﹤0.01% 3619
2020
Q3 		$401K Buy
672
+359
+115% +$232K ﹤0.01% 5484
2020
Q2 		$217K Buy
313
+45
+17% +$56.5K ﹤0.01% 6265
2020
Q1 		$755K Buy
268
+19
+8% +$54.2K ﹤0.01% 3142
2019
Q4 		$614K Buy
249
+59
+31% +$210K ﹤0.01% 3429
2019
Q3 		$960K Sell
190
-29
-13% -$119K ﹤0.01% 2677
2019
Q2 		$787K Sell
219
-29
-12% -$122K ﹤0.01% 3014
2019
Q1 		$912K Buy
+248
New +$1.2M ﹤0.01% 2920
2018
Q4 		– Sell
-42
Closed -$203K – 5364
2018
Q3 		$203K Buy
+42
New +$203K ﹤0.01% 4675
2018
Q1 		– Sell
-20
Closed -$186K – 5139
2017
Q4 		$186K Sell
20
-9
-31% -$89.6K ﹤0.01% 4238
2017
Q3 		$270K Sell
29
-60
-67% -$723K ﹤0.01% 3807
2017
Q2 		$1.22M Buy
89
+69
+345% +$1.33M ﹤0.01% 1984
2017
Q1 		$420K Buy
20
+5
+33% +$124K ﹤0.01% 3049
2016
Q4 		$557K Buy
+15
New +$577K ﹤0.01% 2742
2016
Q3 		– Sell
-25
Closed -$1.83M – 4299
2016
Q2 		$1.83M Sell
25
-27
-52% -$2.18M 0.01% 1352
2016
Q1 		$5.54M Buy
+52
New +$6.66M 0.03% 519

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Jane Street's LABD Position: Q1 2026 in Review

Jane Street increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 89% in Q1 2026, buying an estimated $548K and bringing the position to 61,389 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #6491.

Jane Street first reported a position in LABD in Q2 2015 and has held it in 40 quarters since. The position peaked at $7.13M in Q3 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Jane Street held 61,389 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $1M as of Q1 2026.
  • Jane Street bought 28,929 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $548K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6491 holding.
  • Jane Street first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2015 and has held it in 40 quarters since.
  • Jane Street's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $7.13M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.